MAIA Biotechnology, Inc. (MAIA)
1.35
-0.04
(-2.88%)
USD |
NYAM |
Aug 24, 16:00
1.36
+0.01
(+0.74%)
After-Hours: 20:00
MAIA Biotechnology Total Liabilities (Quarterly) : 7.565M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.565M |
| March 31, 2026 | 7.560M |
| December 31, 2025 | 7.329M |
| September 30, 2025 | 11.74M |
| June 30, 2025 | 7.169M |
| March 31, 2025 | 6.922M |
| December 31, 2024 | 6.521M |
| September 30, 2024 | 7.624M |
| June 30, 2024 | 8.858M |
| March 31, 2024 | 14.48M |
| Date | Value |
|---|---|
| December 31, 2023 | 7.089M |
| September 30, 2023 | 4.253M |
| June 30, 2023 | 3.394M |
| March 31, 2023 | 3.991M |
| December 31, 2022 | 3.514M |
| September 30, 2022 | 2.672M |
| June 30, 2022 | 3.098M |
| March 31, 2022 | 2.431M |
| December 31, 2021 | 2.146M |
| September 30, 2021 | 1.327M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 10.02B |
| TG Therapeutics, Inc. | 1.036B |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.24M |
| Shareholders Equity (Quarterly) | 20.68M |
| Current Ratio | 4.512 |